Arthur S. Kirsch

Insider Reports History

Entity
Individual
Location
7100 West Credit Avenue, Suite 101, C/O Aralez Pharmaceuticals Inc., Mississauga, Ontario, Canada
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Arthur S. Kirsch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur S. Kirsch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Liquidia Corp Director Common Stock 30K $437K $14.55 Jun 20, 2024 Through Revocable Trust of Arthur S. Kirsch
Liquidia Corp Director Common Stock 22.4K $325K $14.55 Jun 20, 2024 Direct
Atea Pharmaceuticals, Inc. Director Common Stock 35.7K $109K $3.06 Feb 20, 2025 Direct
Atea Pharmaceuticals, Inc. Director Common Stock 10K $30.6K $3.06 Feb 20, 2025 By trust
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 165K Feb 20, 2025 Direct
Kadmon Holdings, Inc. Director Common Stock 0 $9.50 Nov 9, 2021 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by Arthur S. Kirsch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Feb 20, 2025 1 $0 4 Feb 24, 2025 Director
AVIR Atea Pharmaceuticals, Inc. Feb 20, 2025 0 $0 3 Feb 24, 2025 Director
LQDA Liquidia Corp Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
LQDA Liquidia Corp Nov 21, 2023 0 $0 4 Nov 22, 2023 Director
LQDA Liquidia Corp Jun 19, 2023 1 $0 4 Jun 21, 2023 Director
LQDA Liquidia Corp Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
LQDA Liquidia Corp Nov 10, 2021 1 $127K 4 Nov 12, 2021 Director
KDMN Kadmon Holdings, Inc. Nov 9, 2021 5 -$2.47M 4 Nov 9, 2021 Director
LQDA Liquidia Corp Aug 20, 2021 1 $0 4 Sep 1, 2021 Director
KDMN Kadmon Holdings, Inc. May 13, 2021 2 $109K 4 May 17, 2021 Director
KDMN Kadmon Holdings, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director